Show simple item record

dc.contributor.authorZeng, Hongmei
dc.contributor.authorChen, Wanqing
dc.contributor.authorZheng, Rongshou
dc.contributor.authorZhang, Siwei
dc.contributor.authorJi, John S
dc.contributor.authorZou, Xiaonong
dc.contributor.authorXia, Changfa
dc.contributor.authorSun, Kexin
dc.contributor.authorYang, Zhixun
dc.contributor.authorLi, He
dc.contributor.authorWang, Ning
dc.contributor.authorHan, Renqiang
dc.contributor.authorLiu, Shuzheng
dc.contributor.authorLi, Huizhang
dc.contributor.authorMu, Huijuan
dc.contributor.authorHe, Yutong
dc.contributor.authorXu, Yanjun
dc.contributor.authorFu, Zhentao
dc.contributor.authorZhou, Yan
dc.contributor.authorJiang, Jie
dc.contributor.authorYang, Yanlei
dc.contributor.authorChen, Jianguo
dc.contributor.authorWei, Kuangrong
dc.contributor.authorFan, Dongmei
dc.contributor.authorWang, Jian
dc.contributor.authorFu, Fangxian
dc.contributor.authorZhao, Deli
dc.contributor.authorSong, Guohui
dc.contributor.authorChen, Jianshun
dc.contributor.authorJiang, Chunxiao
dc.contributor.authorZhou, Xin
dc.contributor.authorGu, Xiaoping
dc.contributor.authorJin, Feng
dc.contributor.authorLi, Qilong
dc.contributor.authorLi, Yanhua
dc.contributor.authorWu, Tonghao
dc.contributor.authorYan, Chunhua
dc.contributor.authorDong, Jianmei
dc.contributor.authorHua, Zhaolai
dc.contributor.authorBaade, Peter
dc.contributor.authorBray, Freddie
dc.contributor.authorJemal, Ahmedin
dc.contributor.authorYu, Xue Qin
dc.contributor.authorHe, Jie
dc.date.accessioned2019-07-05T03:44:34Z
dc.date.available2019-07-05T03:44:34Z
dc.date.issued2018
dc.identifier.issn2214-109X
dc.identifier.doi10.1016/S2214-109X(18)30127-X
dc.identifier.urihttp://hdl.handle.net/10072/386179
dc.description.abstractBackground: From 2003 to 2005, standardised 5-year cancer survival in China was much lower than in developed countries and varied substantially by geographical area. Monitoring population-level cancer survival is crucial to the understanding of the overall effectiveness of cancer care. We therefore aimed to investigate survival statistics for people with cancer in China between 2003 and 2015. Methods: We used population-based data from 17 cancer registries in China. Data for the study population was submitted by the end of July 31, 2016, with follow-up data on vital status obtained on Dec 31, 2015. We used anonymised, individual cancer registration records of patients (aged 0–99 years) diagnosed with primary, invasive cancers from 2003 to 2013. Patients eligible for inclusion had data for demographic characteristics, date of diagnosis, anatomical site, morphology, behaviour code, vital status, and last date of contact. We analysed 5-year relative survival by sex, age, and geographical area, for all cancers combined and 26 different cancer types, between 2003 and 2015. We stratified survival estimates by calendar period (2003–05, 2006–08, 2009–11, and 2012–15). Findings: There were 678 842 records of patients with invasive cancer who were diagnosed between 2003 and 2013. Of these records, 659 732 (97·2%) were eligible for inclusion in the final analyses. From 2003–05 to 2012–15, age-standardised 5-year relative survival increased substantially for all cancers combined, for both male and female patients, from 30·9% (95% CI 30·6–31·2) to 40·5% (40·3–40·7). Age-standardised 5-year relative survival also increased for most cancer types, including cancers of the uterus (average change per calendar period 5·5% [95% CI 2·5–8·5]), thyroid (5·4% [3·2–7·6]), cervix (4·5% [2·9–6·2]), and bone (3·2% [2·1–4·4]). In 2012–15, age-standardised 5-year survival for all patients with cancer was higher in urban areas (46·7%, 95% CI 46·5–47·0) than in rural areas (33·6%, 33·3–33·9), except for patients with oesophageal or cervical cancer; but improvements in survival were greater for patients residing in rural areas than in urban areas. Relative survival decreased with increasing age. The increasing trends in survival were consistent with the upward trends of medical expenditure of the country during the period studied. Interpretation: There was a marked overall increase in cancer survival from 2003 to 2015 in the population covered by these cancer registries in China, possibly reflecting advances in the quality of cancer care in these areas. The survival gap between urban and rural areas narrowed over time, although geographical differences in cancer survival remained. Insight into these trends will help prioritise areas that need increased cancer care.
dc.description.peerreviewedYes
dc.languageEnglish
dc.language.isoeng
dc.publisherElsevier
dc.relation.ispartofpagefromE555
dc.relation.ispartofpagetoE567
dc.relation.ispartofissue5
dc.relation.ispartofjournalLancet Global Health
dc.relation.ispartofvolume6
dc.subject.fieldofresearchLaw
dc.subject.fieldofresearchMicrobiology
dc.subject.fieldofresearchPublic Health and Health Services
dc.subject.fieldofresearchcode1801
dc.subject.fieldofresearchcode0605
dc.subject.fieldofresearchcode1117
dc.titleChanging cancer survival in China during 2003-15: a pooled analysis of 17 population-based cancer registries
dc.typeJournal article
dc.type.descriptionC1 - Articles
dc.type.codeC - Journal Articles
dcterms.licensehttp://creativecommons.org/licenses/by/4.0/
dc.description.versionVersion of Record (VoR)
gro.rights.copyrightCopyright © 2018 The Author(s). Published by Elsevier Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution 4.0 International License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
gro.hasfulltextFull Text
gro.griffith.authorBaade, Peter D.


Files in this item

This item appears in the following Collection(s)

  • Journal articles
    Contains articles published by Griffith authors in scholarly journals.

Show simple item record